ARTICLE | Finance
Bugs in the clinic
Newco Seres first to the clinic in microbiome space, targeting C. difficile
November 25, 2013 8:00 AM UTC
Newco Seres Health Inc. has emerged from stealth mode, and the Flagship Ventures startup believes it already has at least one leg up on other microbiome companies - a program in the clinic.
Seres has been operating out of Flagship VentureLabs for two and a half years, CEO David Berry told BioCentury. Last week, the company disclosed it had raised $10.5 million in a series A round led by Flagship with participation from Enso Ventures...